The top-five pathways significantly enriched for GRIN1 were neuroactive ligand–receptor interaction, arginine and proline metabolism, Parkinson’s disease, ribosome, and basal cell carcinoma (Figure 5B). Here, GRIN1 is linked to Parkinson disease.